: COVID-19 has a mild clinical course with low mortality rate in general pediatric population, while variable outcomes have been described in children with cancer. Infectious diseases working party of the AIEOP collected data on the clinical characteristics and outcomes of SARS-CoV-2 infections in pediatric oncology/hematology patients from April 2020 to May 2021, including the second and the third waves of the pandemic in Italy. Factors potentially associated with moderate, severe, or critical COVID-19 were analyzed. Of the 153 SARS-Cov2 infections recorded, 100 were asymptomatic and 53 symptomatic. The course of COVID-19 was mild in 41, moderate in 2, severe in 5, and critical in 5 children. A total of 40.5% of patients were hospitalized,...
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has be...
The pediatric population seems to be at a lower risk of developing severe clinical symptoms of COVID...
PURPOSE There are limited data on SARS-CoV-2 (COVID-19) infection in children with cancer or afte...
COVID-19 has a mild clinical course with low mortality rate in general pediatric population, while v...
none13noBackground. Little is known as yet about the outcome of severe acute respiratory syndrome co...
Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear and opti...
Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome ...
Vaccines represent the best tool to prevent the severity course and fatal consequences of the pandem...
Detailed data on clinical presentations and outcomes of children with COVID-19 in Europe are still l...
Pediatric cancer patients are immunocompromised, and the risks are higher in this population. Confir...
In December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been repor...
Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and ado...
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has be...
Introduction: Coronavirus disease 2019 (COVID-19) pandemic started in Italy with clusters identified...
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has be...
The pediatric population seems to be at a lower risk of developing severe clinical symptoms of COVID...
PURPOSE There are limited data on SARS-CoV-2 (COVID-19) infection in children with cancer or afte...
COVID-19 has a mild clinical course with low mortality rate in general pediatric population, while v...
none13noBackground. Little is known as yet about the outcome of severe acute respiratory syndrome co...
Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear and opti...
Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome ...
Vaccines represent the best tool to prevent the severity course and fatal consequences of the pandem...
Detailed data on clinical presentations and outcomes of children with COVID-19 in Europe are still l...
Pediatric cancer patients are immunocompromised, and the risks are higher in this population. Confir...
In December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been repor...
Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and ado...
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has be...
Introduction: Coronavirus disease 2019 (COVID-19) pandemic started in Italy with clusters identified...
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has be...
The pediatric population seems to be at a lower risk of developing severe clinical symptoms of COVID...
PURPOSE There are limited data on SARS-CoV-2 (COVID-19) infection in children with cancer or afte...